Bausch Health Companies (BHC) Liabilities from Discontinued Operations (2010 - 2017)

Bausch Health Companies' (BHC) quarterly Liabilities from Discontinued Operations came in at 22000000.0 in Q2 2017, down 54.17% quarter-over-quarter from 48000000.0 in Q1 2017.

Bausch Health Companies (BHC) Liabilities from Discontinued Operations (2010 - 2017) Analysis & Trends

Bausch Health Companies has disclosed Liabilities from Discontinued Operations across 4 years of filings, most recently posting 22000000.0 for Q2 2017.

  • Liabilities from Discontinued Operations for Q2 2017 came in at 22000000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2017 was 22000000.0 (changed N/A YoY), and the FY2016 annual result was 57000000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at 22000000.0 for Q2 2017 at Bausch Health Companies, down from 48000000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 57000000.0 in Q4 2016 to a low of 22000000.0 in Q2 2017.
  • The 3-year median for Liabilities from Discontinued Operations is 37550000.0 (2014), against an average of 38525000.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Bausch Health Companies 1.93 Bn 1.59 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Jun 30, 2017 22.00 Mn
Jun 30, 2017 22.00 Mn
Mar 31, 2017 48.00 Mn
Mar 31, 2017 48.00 Mn
Dec 31, 2016 57.00 Mn
Dec 31, 2016 57.00 Mn
Jun 30, 2014 27.10 Mn
Jun 30, 2014 27.10 Mn
Jun 30, 2010 1.08 Mn
Jun 30, 2010 1.08 Mn